Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Accelrys To Merge With Symyx Technologies
The merger, structured as a tax-free, all-stock merger of equals, was approved by both companies’ boards of directors. On a combined basis, Accelrys and Sym have a pre-announcement
The merger, structured as a tax-free, all-stock merger of equals, was approved by both companies’ boards of directors. On a combined basis, Accelrys and Sym have a pre-announcement
MMR said that the PHR will be powered by MMR Information Systems, incorporating its MyMedicalRecords patented technologies and will initially be available in English, Spanish, German, French, Italian,
The project is undertaken jointly by NCBS, Stanford University and Technical University of Denmark. VLife Sciences Technologies said that the project involves studying coiled coil interactions in proteins
BioClinica said that with this acquisition, it has enhanced its ability to serve customers throughout the clinical research process with technologies that include improved efficiencies by reducing study
Keyrus Biopharma has gained flexibility in designing clinical trials and managing data collection, as well as increased scalability to support business expansion, with Oracle Clinical. The solution provides
Pharmaceutical brands build websites primarily to drive drug adoption. Most importantly, the brands need to know which content areas drive the desired behaviors and which content areas do
The next-generation primary care record under development by Mayo Clinic and VitalHealth Software expects to create simplicity at the point of care while contributing to quality of care
The acquisition provides Abbott with products and expertise to build its position in laboratory informatics, an emerging and rapidly growing field focused on helping to manage the increasing
The latest contract, worth GBP6m, extends the original $47.8m agreement, signed in March 2008, to 2016. It expands the services offered and includes new HP hardware and infrastructure
Cadence submitted its first new drug application in May 2009 for intravenous acetaminophen, its investigational product candidate. It has partnered with ISI to identify the best delivery model